Saliva can be more effective than nasopharyngeal swabs for COVID-19 testing

Study identifies how COVID-19 linked to Alzheimer’s disease-like cognitive impairment
10 June 2021
Study examines the effects of COVID-19 on human kidney cells
10 June 2021

Saliva can be more effective than nasopharyngeal swabs for COVID-19 testing

The collection of nasopharyngeal swab (NPS) samples for COVID-19 diagnostic testing poses challenges including exposure risk to healthcare workers and supply chain constraints. Saliva samples are easier to collect but can be mixed with mucus or blood, and some studies have found they produce less accurate results. A team of researchers has found that an innovative protocol that processes saliva samples with a bead mill homogenizer before real-time PCR (RT-PCR) testing results in higher sensitivity compared to NPS samples. Their protocol appears in The Journal of Molecular Diagnostics.

Comments are closed.